Modifying DNA to eradicate cancer...
55 Church St, New Haven, CT
Joined May 2024
- Tweets6
- Following12
- Followers23
- Likes1
We look forward to translating this amazing Yale science into the clinic next year, for #gbm patients and beyond 💫
#btsm
#defeatgbm
#benchtobedside
@yalecancer
@yaleventures
@CT_Innovate
@BioCT_org
@ACSBrightEdge
@sontagfdn
@NBTStweets
This is a labor of love led by the @HerzonLab, which highlights the benefits of creative, cross-disciplinary collaborations in science…excited to drive this into the clinic at light speed 🙏🏽🙌🏽
@YaleRadOnc
@YaleChem
@yalepathology
@YaleCancer
@Yale_Ventures
@modifibio
Modifi Bio is very excited to bring this class of drugs into the clinic for glioma + many other MGMT-deficient tumors!
@ranjitbindra
@HerzonLab
@LinKingson
#biotech
#startuplife
#DIY
@yaleventures
@CT_Innovate
@BioCT_org
@NBTStweets
@NBTSCSO
@sontagfdn
@ACSBrightEdge
This is been a truly wonderful collaboration, drawing on the @HerzonLab mastery of synthetic chemistry and our lab's focus of exploiting DDR defects for a therapeutic gain! An entirely new way to treat tumors with DNA modifiers!
@YaleChem
@YaleRadOnc
@YaleCancer
@modifibio
modifibio retweeted
This stuff is so cool. I am so amazingly lucky to have a front row seat to the cutting edge of cancer therapy!
We are very excited to translate this work into the clinic soon, for patients with MGMT-deficient brain tumors and beyond! #biotech #science #btsm
@yaleventures
@CT_Innovate
@BioCT_org
@Advance_CT
@NBTStweets
@NBTSCSO
Modifi Bio is similarly grateful to have @LinKingson as one of its scientific co-founders! We are excited to translate his work into the brain tumor clinic next summer 👏🤜
Forever grateful to work with such talented trainees like @LinKingson @ForbesUnder30 @PDSoros @YaleRadOnc @YaleCancer @yalepathology
🙏🏽👇🏽👏🏽👊🏽
#academia
#science
Very excited to have Dr. LoRusso on the @modifibio SAB, a true force of nature!
Spotted! Amazing breakfast with med onc/peds onc zen masters/mentors/friends, Pat LoRusso and @drsam!
#asco2024
@YaleCancer
@YaleRadOnc
@ASCO
@DayOneBio
@modifibio
@Cybrexa
We are very excited to translate this work into the clinic soon, for patients with MGMT-deficient brain tumors and beyond! #biotech #science #btsm
@yaleventures
@CT_Innovate
@BioCT_org
@Advance_CT
@NBTStweets
@NBTSCSO
It’s out! Our follow-up study on KL50, a novel DNA modifier that exploits brain tumor DDR defects! Grateful for the opportunity to collaborate w/ the @HerzonLab on this exciting project.
@LinKingson @YaleRadOnc @YaleCancer
@Yale_Ventures @modifibio
pubs.acs.org/doi/full/10.102…
